ClinicalTrials.Veeva

Menu

Coronary Revascularisation by rePOT (CABRIOLET)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Coronary Disease

Treatments

Other: Provisional stenting with rePOT technique

Study type

Observational

Funder types

Other

Identifiers

NCT03550196
69HCL17_0877

Details and patient eligibility

About

The presence of a coronary bifurcation complicates percutaneous revascularization. Bifurcation stenting needs to take into account the difference of diameter between proximal and distal vessels and the necessity to limit the side branch obstruction. Provisional stenting techniques with balloon juxtaposition as Kissing Balloon Inflation (KBI) fail to demonstrate a clinical benefits. This is probably explain by the detrimental effect during these technics on the proximal segment with an arterial overstretch. A new sequential technique, named rePOT, demonstrated experimentally a mechanical superiority compared to juxtaposition balloon techniques included KBI. RePOT associates an initial proximal optimizing technique (POT), a side branch inflation and a final POT.

A first clinical study (n=106 patients) confirmed these excellent mechanical results with serial OCT analysis and demonstrated an excellent short term safety. Since 2017, rePOT is recommended in Europe in clinical practice.

This large registry is dedicated to confirm the clinical benefits at long term after bifurcation revascularization with rePOT technique before a large randomise trial.

Enrollment

500 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Discovery, during angiography, of a significant coronary lesion (by angiographic or functional assessment) including a bifurcation under a provisional stenting strategy. Bifurcation have to be significant according to the operator and the coronary anatomy (but the side branch diameter have to be greater than 1.75mm)
  • Stable lesion without high thrombus burden
  • Patient agreement to study participation and ≥ 18 years

Exclusion criteria

  • Complex lesion or anatomy requiring revascularization strategy with more than one stent
  • Contraindication to a double platelet anti-aggregation ≥ 6mois (recommended implantation of active stent)
  • Unstable patient according to the operator (used of hemodynamic drug support, mechanical ventilation)
  • Indication of cardiac surgery.
  • Lesion culprit in ST- or non ST-elevation myocardial infarction <12h.
  • High thrombus burden in angiography or endocoronary imaging (IVUS, OCT).
  • Pregnancy, loose of legal right
  • Other interventional study participation <30 jours.

Trial contacts and locations

4

Loading...

Central trial contact

Gérard FINET, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems